# Page snapshot

```yaml
- generic [ref=e3]:
  - banner [ref=e4]:
    - generic [ref=e5]:
      - img "OpenOnco" [ref=e7] [cursor=pointer]
      - navigation [ref=e8]:
        - button "Home" [ref=e9] [cursor=pointer]
        - button "Submissions" [ref=e10] [cursor=pointer]
        - button "How it Works" [ref=e11] [cursor=pointer]
        - button "Data Download" [ref=e12] [cursor=pointer]
        - button "FAQ" [ref=e13] [cursor=pointer]
        - button "Learn" [ref=e14] [cursor=pointer]
        - button "About" [ref=e15] [cursor=pointer]
  - main [ref=e16]:
    - generic [ref=e18]:
      - generic [ref=e19]: "Build: Dec 14, 2025, 10:05 PM PST"
      - 'heading "Advanced Molecular Diagnostics: Collected, Curated, Explained" [level=1] [ref=e21]'
      - generic [ref=e23]:
        - generic [ref=e24]:
          - generic [ref=e25]:
            - heading "Explore Tests by Category" [level=3] [ref=e26]
            - generic [ref=e28]:
              - 'button "üî¨ Healthy / Screening: ECD Early Cancer Detection Click to explore 16 tests ‚Üí Galleri ‚Ä¢ Shield ‚Ä¢ Cancerguard ‚Ä¢ Freenome CRC ‚Ä¢ GRAIL NHS ‚Ä¢ Cologuard Plus ‚Ä¢ Galleri ‚Ä¢ Shield ‚Ä¢ Cancerguard ‚Ä¢ Freenome CRC ‚Ä¢ GRAIL NHS ‚Ä¢ Cologuard Plus ‚Ä¢" [ref=e29] [cursor=pointer]':
                - generic [ref=e30]:
                  - generic [ref=e32]: üî¨
                  - generic [ref=e33]:
                    - 'heading "Healthy / Screening: ECD" [level=3] [ref=e34]'
                    - paragraph [ref=e35]: Early Cancer Detection
                    - paragraph [ref=e36]: Click to explore 16 tests ‚Üí
                - generic [ref=e40]: Galleri ‚Ä¢ Shield ‚Ä¢ Cancerguard ‚Ä¢ Freenome CRC ‚Ä¢ GRAIL NHS ‚Ä¢ Cologuard Plus ‚Ä¢ Galleri ‚Ä¢ Shield ‚Ä¢ Cancerguard ‚Ä¢ Freenome CRC ‚Ä¢ GRAIL NHS ‚Ä¢ Cologuard Plus ‚Ä¢
                - img [ref=e43]
              - 'button "üß¨ Newly Diagnosed: TDS Treatment Decision Support Click to explore 28 tests ‚Üí FoundationOne CDx ‚Ä¢ Guardant360 CDx ‚Ä¢ Tempus xT CDx ‚Ä¢ MSK-IMPACT ‚Ä¢ MI Cancer Seek ‚Ä¢ OncoExTra ‚Ä¢ FoundationOne CDx ‚Ä¢ Guardant360 CDx ‚Ä¢ Tempus xT CDx ‚Ä¢ MSK-IMPACT ‚Ä¢ MI Cancer Seek ‚Ä¢ OncoExTra ‚Ä¢" [ref=e45] [cursor=pointer]':
                - generic [ref=e46]:
                  - generic [ref=e48]: üß¨
                  - generic [ref=e49]:
                    - 'heading "Newly Diagnosed: TDS" [level=3] [ref=e50]'
                    - paragraph [ref=e51]: Treatment Decision Support
                    - paragraph [ref=e52]: Click to explore 28 tests ‚Üí
                - generic [ref=e56]: FoundationOne CDx ‚Ä¢ Guardant360 CDx ‚Ä¢ Tempus xT CDx ‚Ä¢ MSK-IMPACT ‚Ä¢ MI Cancer Seek ‚Ä¢ OncoExTra ‚Ä¢ FoundationOne CDx ‚Ä¢ Guardant360 CDx ‚Ä¢ Tempus xT CDx ‚Ä¢ MSK-IMPACT ‚Ä¢ MI Cancer Seek ‚Ä¢ OncoExTra ‚Ä¢
                - img [ref=e59]
              - 'button "üìä Active Treatment: TRM Treatment Response Monitoring Click to explore 10 tests ‚Üí Reveal TRM ‚Ä¢ Signatera (IO Monitoring) ‚Ä¢ NeXT Personal ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢ Reveal TRM ‚Ä¢ Signatera (IO Monitoring) ‚Ä¢ NeXT Personal ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢" [ref=e61] [cursor=pointer]':
                - generic [ref=e62]:
                  - generic [ref=e64]: üìä
                  - generic [ref=e65]:
                    - 'heading "Active Treatment: TRM" [level=3] [ref=e66]'
                    - paragraph [ref=e67]: Treatment Response Monitoring
                    - paragraph [ref=e68]: Click to explore 10 tests ‚Üí
                - generic [ref=e72]: Reveal TRM ‚Ä¢ Signatera (IO Monitoring) ‚Ä¢ NeXT Personal ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢ Reveal TRM ‚Ä¢ Signatera (IO Monitoring) ‚Ä¢ NeXT Personal ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢
                - img [ref=e75]
              - 'button "üéØ Surveillance: MRD Minimal Residual Disease Click to explore 25 tests ‚Üí Signatera ‚Ä¢ Reveal MRD ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢ Invitae Personalis ‚Ä¢ FoundationOne Tracker ‚Ä¢ Signatera ‚Ä¢ Reveal MRD ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢ Invitae Personalis ‚Ä¢ FoundationOne Tracker ‚Ä¢" [ref=e77] [cursor=pointer]':
                - generic [ref=e78]:
                  - generic [ref=e80]: üéØ
                  - generic [ref=e81]:
                    - 'heading "Surveillance: MRD" [level=3] [ref=e82]'
                    - paragraph [ref=e83]: Minimal Residual Disease
                    - paragraph [ref=e84]: Click to explore 25 tests ‚Üí
                - generic [ref=e88]: Signatera ‚Ä¢ Reveal MRD ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢ Invitae Personalis ‚Ä¢ FoundationOne Tracker ‚Ä¢ Signatera ‚Ä¢ Reveal MRD ‚Ä¢ RaDaR ‚Ä¢ Oncodetect ‚Ä¢ Invitae Personalis ‚Ä¢ FoundationOne Tracker ‚Ä¢
                - img [ref=e91]
          - generic [ref=e93]:
            - heading "Explore Tests by AI" [level=3] [ref=e94]
            - generic [ref=e95] [cursor=pointer]:
              - generic [ref=e96]:
                - generic [ref=e97]:
                  - textbox "Ask Claude about tests..." [ref=e98]
                  - img [ref=e99]
                - generic [ref=e101]:
                  - combobox "Select AI model" [ref=e102]:
                    - option "More speed" [selected]
                    - option "More thinking"
                  - button "Ask" [disabled] [ref=e103]
              - generic [ref=e105]:
                - generic [ref=e106]: "Try asking:"
                - button "Compare Signatera and Reveal MRD for MRD monitoring" [ref=e107]
                - button "Which TDS tests have the fastest turnaround time?" [ref=e108]
                - button "ü©∫ I am a patient, please use straightforward language" [ref=e109]
                - button "üë®‚Äç‚öïÔ∏è I am a physician, please use clinical language" [ref=e110]
            - generic [ref=e111] [cursor=pointer]:
              - paragraph [ref=e112]: "Or: Quick Search"
              - generic [ref=e113]:
                - textbox "Filter by name, vendor, cancer..." [ref=e114]
                - img [ref=e115]
        - generic [ref=e117]:
          - generic [ref=e118]:
            - paragraph [ref=e119]: All the tests we track (79)
            - generic [ref=e120]:
              - generic [ref=e121]: "Sort:"
              - combobox [ref=e122] [cursor=pointer]:
                - option "Alphabetical" [selected]
                - option "By Category"
                - option "By TAT (fastest)"
                - option "By Coverage"
                - 'option "By # Tests"'
                - option "By Openness"
          - generic [ref=e123]:
            - generic [ref=e124] [cursor=pointer]:
              - generic [ref=e125]:
                - generic [ref=e126]:
                  - paragraph [ref=e127]: BD OneFlow B-ALL MRD Kit
                  - paragraph [ref=e128]: BD Biosciences
                - generic [ref=e129]:
                  - generic "Laboratory IVD Kit" [ref=e130]: üî¨Kit
                  - generic [ref=e131]: MRD
              - generic [ref=e132]:
                - generic [ref=e133]: "Sens: 96%"
                - generic [ref=e134]: "Spec: 95%"
                - generic [ref=e135]: "TAT: 1d"
            - generic [ref=e136] [cursor=pointer]:
              - generic [ref=e137]:
                - generic [ref=e138]:
                  - paragraph [ref=e139]: CancerDetect
                  - paragraph [ref=e140]: IMBdx
                - generic [ref=e142]: MRD
              - generic [ref=e143]:
                - generic [ref=e144]: "Spec: 99.9%"
                - generic [ref=e145]: "TAT: 28d"
                - generic [ref=e146]: "Pubs: 2"
            - generic [ref=e147] [cursor=pointer]:
              - generic [ref=e148]:
                - generic [ref=e149]:
                  - paragraph [ref=e150]: Cancerguard
                  - paragraph [ref=e151]:
                    - text: Exact Sciences
                    - generic "Top 3 in OpenOnco Data Openness Ranking" [ref=e152]:
                      - generic [ref=e153]: üìä
                - generic [ref=e155]: ECD
              - generic [ref=e156]:
                - generic [ref=e157]: "Sens: 64%"
                - generic [ref=e158]: "Spec: 97.4%"
                - generic [ref=e159]: "Pubs: 2"
            - generic [ref=e160] [cursor=pointer]:
              - generic [ref=e161]:
                - generic [ref=e162]:
                  - paragraph [ref=e163]: Caris Assure
                  - paragraph [ref=e164]: Caris Life Sciences
                - generic [ref=e166]: MRD
              - generic [ref=e167]:
                - generic [ref=e168]: "Spec: 99.6%"
                - generic [ref=e169]: "TAT: 14d"
                - generic [ref=e170]: "Pubs: 5"
            - generic [ref=e171] [cursor=pointer]:
              - generic [ref=e172]:
                - generic [ref=e173]:
                  - paragraph [ref=e174]: Caris Assure
                  - paragraph [ref=e175]: Caris Life Sciences
                - generic [ref=e177]: TRM
              - generic [ref=e178]:
                - generic [ref=e179]: "Sens: 93.8%"
                - generic [ref=e180]: "Spec: 99.99%"
                - generic [ref=e181]: "TAT: 10d"
            - generic [ref=e182] [cursor=pointer]:
              - generic [ref=e183]:
                - generic [ref=e184]:
                  - paragraph [ref=e185]: clonoSEQ
                  - paragraph [ref=e186]: Adaptive Biotechnologies
                - generic [ref=e188]: MRD
              - generic [ref=e189]:
                - generic [ref=e190]: "TAT: 14d"
                - generic [ref=e191]: "Pubs: 100"
                - generic [ref=e192]: "$: 2.0k"
            - generic [ref=e193] [cursor=pointer]:
              - generic [ref=e194]:
                - generic [ref=e195]:
                  - paragraph [ref=e196]: clonoSEQ Assay
                  - paragraph [ref=e197]: Adaptive Biotechnologies
                - generic [ref=e198]:
                  - generic "Laboratory IVD Kit" [ref=e199]: üî¨Kit
                  - generic [ref=e200]: MRD
              - generic [ref=e201]:
                - generic [ref=e202]: "Sens: 95%"
                - generic [ref=e203]: "Spec: 99%"
                - generic [ref=e204]: "TAT: 7d"
            - generic [ref=e205] [cursor=pointer]:
              - generic [ref=e206]:
                - generic [ref=e207]:
                  - paragraph [ref=e208]: cobas EGFR Mutation Test v2
                  - paragraph [ref=e209]: Roche
                - generic [ref=e210]:
                  - generic "Laboratory IVD Kit" [ref=e211]: üî¨Kit
                  - generic [ref=e212]: TDS
              - generic [ref=e213]:
                - generic [ref=e214]: "Sens: 85%"
                - generic [ref=e215]: "Spec: 98%"
                - generic [ref=e216]: "TAT: 1d"
            - generic [ref=e217] [cursor=pointer]:
              - generic [ref=e218]:
                - generic [ref=e219]:
                  - paragraph [ref=e220]: cobas KRAS Mutation Test
                  - paragraph [ref=e221]: Roche
                - generic [ref=e222]:
                  - generic "Laboratory IVD Kit" [ref=e223]: üî¨Kit
                  - generic [ref=e224]: TDS
              - generic [ref=e225]:
                - generic [ref=e226]: "Sens: 95%"
                - generic [ref=e227]: "Spec: 99%"
                - generic [ref=e228]: "TAT: 1d"
            - generic [ref=e229] [cursor=pointer]:
              - generic [ref=e230]:
                - generic [ref=e231]:
                  - paragraph [ref=e232]: Cologuard
                  - paragraph [ref=e233]:
                    - text: Exact Sciences
                    - generic "Top 3 in OpenOnco Data Openness Ranking" [ref=e234]:
                      - generic [ref=e235]: üìä
                - generic [ref=e236]:
                  - generic "Self-Collection" [ref=e237]: üè†Home
                  - generic [ref=e238]: ECD
              - generic [ref=e239]:
                - generic [ref=e240]: "Sens: 92%"
                - generic [ref=e241]: "Spec: 87%"
                - generic [ref=e242]: "TAT: 1d"
            - generic [ref=e243] [cursor=pointer]:
              - generic [ref=e244]:
                - generic [ref=e245]:
                  - paragraph [ref=e246]: Cologuard Plus
                  - paragraph [ref=e247]:
                    - text: Exact Sciences
                    - generic "Top 3 in OpenOnco Data Openness Ranking" [ref=e248]:
                      - generic [ref=e249]: üìä
                - generic [ref=e251]: ECD
              - generic [ref=e252]:
                - generic [ref=e253]: "Sens: 93.9%"
                - generic [ref=e254]: "Spec: 91%"
                - generic [ref=e255]: "TAT: 3d"
            - generic [ref=e256] [cursor=pointer]:
              - generic [ref=e257]:
                - generic [ref=e258]:
                  - paragraph [ref=e259]: ColoSense
                  - paragraph [ref=e260]: Geneoscopy
                - generic [ref=e262]: ECD
              - generic [ref=e263]:
                - generic [ref=e264]: "Sens: 93%"
                - generic [ref=e265]: "Spec: 88%"
                - generic [ref=e266]: "Pubs: 3"
            - generic [ref=e267] [cursor=pointer]:
              - generic [ref=e268]:
                - generic [ref=e269]:
                  - paragraph [ref=e270]: Epi proColon
                  - paragraph [ref=e271]: Epigenomics
                - generic [ref=e272]:
                  - generic "Laboratory IVD Kit" [ref=e273]: üî¨Kit
                  - generic [ref=e274]: ECD
              - generic [ref=e275]:
                - generic [ref=e276]: "Sens: 68%"
                - generic [ref=e277]: "Spec: 80%"
                - generic [ref=e278]: "TAT: 3d"
            - generic [ref=e279] [cursor=pointer]:
              - generic [ref=e280]:
                - generic [ref=e281]:
                  - paragraph [ref=e282]: EPISEEK
                  - paragraph [ref=e283]: Precision Epigenomics
                - generic [ref=e285]: ECD
              - generic [ref=e286]:
                - generic [ref=e287]: "Sens: 54%"
                - generic [ref=e288]: "Spec: 99.5%"
                - generic [ref=e289]: "TAT: 5d"
            - generic [ref=e290] [cursor=pointer]:
              - generic [ref=e291]:
                - generic [ref=e292]:
                  - paragraph [ref=e293]: FirstLook Lung
                  - paragraph [ref=e294]: DELFI Diagnostics
                - generic [ref=e296]: ECD
              - generic [ref=e297]:
                - generic [ref=e298]: "Sens: 80%"
                - generic [ref=e299]: "Spec: 58%"
                - generic [ref=e300]: "TAT: 10d"
            - generic [ref=e301] [cursor=pointer]:
              - generic [ref=e302]:
                - generic [ref=e303]:
                  - paragraph [ref=e304]: Foresight CLARITY Lymphoma
                  - paragraph [ref=e305]: Natera
                - generic [ref=e307]: MRD
              - generic [ref=e308]:
                - generic [ref=e309]: "Sens: 90.62%"
                - generic [ref=e310]: "Spec: 97.65%"
                - generic [ref=e311]: "TAT: 8d"
            - generic [ref=e312] [cursor=pointer]:
              - generic [ref=e313]:
                - generic [ref=e314]:
                  - paragraph [ref=e315]: Foundation TI-WGS MRD (RUO)
                  - paragraph [ref=e316]: Foundation Medicine
                - generic [ref=e318]: MRD
              - generic [ref=e320]: No data
            - generic [ref=e321] [cursor=pointer]:
              - generic [ref=e322]:
                - generic [ref=e323]:
                  - paragraph [ref=e324]: FoundationOne CDx
                  - paragraph [ref=e325]: Foundation Medicine
                - generic [ref=e327]: TDS
              - generic [ref=e328]:
                - generic [ref=e329]: "TAT: 8d"
                - generic [ref=e330]: "Pubs: 1000"
                - generic [ref=e331]: "$: 3.5k"
            - generic [ref=e332] [cursor=pointer]:
              - generic [ref=e333]:
                - generic [ref=e334]:
                  - paragraph [ref=e335]: FoundationOne Heme
                  - paragraph [ref=e336]: Foundation Medicine
                - generic [ref=e338]: TDS
              - generic [ref=e339]:
                - generic [ref=e340]: "TAT: 10d"
                - generic [ref=e341]: "$: 3.5k"
            - generic [ref=e342] [cursor=pointer]:
              - generic [ref=e343]:
                - generic [ref=e344]:
                  - paragraph [ref=e345]: FoundationOne Liquid CDx
                  - paragraph [ref=e346]: Foundation Medicine
                - generic [ref=e348]: TDS
              - generic [ref=e349]:
                - generic [ref=e350]: "TAT: 7d"
                - generic [ref=e351]: "$: 3.5k"
            - generic [ref=e352] [cursor=pointer]:
              - generic [ref=e353]:
                - generic [ref=e354]:
                  - paragraph [ref=e355]: FoundationOne Monitor
                  - paragraph [ref=e356]: Foundation Medicine
                - generic [ref=e358]: TRM
              - generic [ref=e360]: "Pubs: 3"
            - generic [ref=e361] [cursor=pointer]:
              - generic [ref=e362]:
                - generic [ref=e363]:
                  - paragraph [ref=e364]: FoundationOne Tracker (MRD)
                  - paragraph [ref=e365]: Foundation Medicine / Natera
                - generic [ref=e367]: MRD
              - generic [ref=e369]: "Pubs: 3"
            - generic [ref=e370] [cursor=pointer]:
              - generic [ref=e371]:
                - generic [ref=e372]:
                  - paragraph [ref=e373]: FoundationOne Tracker (TRM)
                  - paragraph [ref=e374]: Foundation Medicine / Natera
                - generic [ref=e376]: TRM
              - generic [ref=e378]: "Pubs: 4"
            - generic [ref=e379] [cursor=pointer]:
              - generic [ref=e380]:
                - generic [ref=e381]:
                  - paragraph [ref=e382]: Freenome CRC Blood Test
                  - paragraph [ref=e383]: Freenome
                - generic [ref=e385]: ECD
              - generic [ref=e386]:
                - generic [ref=e387]: "Sens: 79.2%"
                - generic [ref=e388]: "Spec: 91.5%"
                - generic [ref=e389]: "Pubs: 2"
            - generic [ref=e390] [cursor=pointer]:
              - generic [ref=e391]:
                - generic [ref=e392]:
                  - paragraph [ref=e393]: Galleri
                  - paragraph [ref=e394]: GRAIL
                - generic [ref=e396]: ECD
              - generic [ref=e397]:
                - generic [ref=e398]: "Sens: 51.5%"
                - generic [ref=e399]: "Spec: 99.5%"
                - generic [ref=e400]: "TAT: 10d"
            - generic [ref=e401] [cursor=pointer]:
              - generic [ref=e402]:
                - generic [ref=e403]:
                  - paragraph [ref=e404]: GeneseeqPrime
                  - paragraph [ref=e405]: Geneseeq Technology
                - generic [ref=e406]:
                  - generic "Laboratory IVD Kit" [ref=e407]: üî¨Kit
                  - generic [ref=e408]: TDS
              - generic [ref=e409]:
                - generic [ref=e410]: "TAT: 7d"
                - generic [ref=e411]: "Pubs: 100"
            - generic [ref=e412] [cursor=pointer]:
              - generic [ref=e413]:
                - generic [ref=e414]:
                  - paragraph [ref=e415]: Guardant LUNAR (RUO platform)
                  - paragraph [ref=e416]: Guardant Health
                - generic [ref=e418]: MRD
              - generic [ref=e419]:
                - generic [ref=e420]: "Sens: 56%"
                - generic [ref=e421]: "Spec: 100%"
                - generic [ref=e422]: "Pubs: 5"
            - generic [ref=e423] [cursor=pointer]:
              - generic [ref=e424]:
                - generic [ref=e425]:
                  - paragraph [ref=e426]: Guardant360 CDx
                  - paragraph [ref=e427]: Guardant Health
                - generic [ref=e429]: TDS
              - generic [ref=e430]:
                - generic [ref=e431]: "TAT: 5d"
                - generic [ref=e432]: "Pubs: 150"
            - generic [ref=e433] [cursor=pointer]:
              - generic [ref=e434]:
                - generic [ref=e435]:
                  - paragraph [ref=e436]: Guardant360 Liquid
                  - paragraph [ref=e437]: Guardant Health
                - generic [ref=e439]: TDS
              - generic [ref=e440]:
                - generic [ref=e441]: "Spec: ‚â•99.9%"
                - generic [ref=e442]: "TAT: 7d"
            - generic [ref=e443] [cursor=pointer]:
              - generic:
                - generic: DISCONTINUED
              - generic [ref=e444]:
                - generic [ref=e445]:
                  - paragraph [ref=e446]: Guardant360 Response
                  - paragraph [ref=e447]: Guardant Health
                - generic [ref=e448]: DISC
              - generic [ref=e450]: "Pubs: 40"
            - generic [ref=e451] [cursor=pointer]:
              - generic [ref=e452]:
                - generic [ref=e453]:
                  - paragraph [ref=e454]: Haystack MRD
                  - paragraph [ref=e455]: Quest Diagnostics
                - generic [ref=e457]: MRD
              - generic [ref=e458]:
                - generic [ref=e459]: "Sens: 95%"
                - generic [ref=e460]: "TAT: 30d"
                - generic [ref=e461]: "Pubs: 17"
            - generic [ref=e462] [cursor=pointer]:
              - generic [ref=e463]:
                - generic [ref=e464]:
                  - paragraph [ref=e465]: HelioLiver
                  - paragraph [ref=e466]: Helio Genomics
                - generic [ref=e468]: ECD
              - generic [ref=e469]:
                - generic [ref=e470]: "Sens: 85%"
                - generic [ref=e471]: "Spec: 91%"
                - generic [ref=e472]: "Pubs: 2"
            - generic [ref=e473] [cursor=pointer]:
              - generic [ref=e474]:
                - generic [ref=e475]:
                  - paragraph [ref=e476]: IColocomf
                  - paragraph [ref=e477]: Wuhan Ammunition Life Technology
                - generic [ref=e479]: ECD
              - generic [ref=e480]:
                - generic [ref=e481]: "Sens: 95.31%"
                - generic [ref=e482]: "Spec: 96.67%"
                - generic [ref=e483]: "TAT: 3d"
            - generic [ref=e484] [cursor=pointer]:
              - generic [ref=e485]:
                - generic [ref=e486]:
                  - paragraph [ref=e487]: Invitae PCM
                  - paragraph [ref=e488]: Labcorp (Invitae)
                - generic [ref=e490]: MRD
              - generic [ref=e491]:
                - generic [ref=e492]: "Sens: 76.9%"
                - generic [ref=e493]: "Spec: 100%"
                - generic [ref=e494]: "TAT: 21d"
            - generic [ref=e495] [cursor=pointer]:
              - generic [ref=e496]:
                - generic [ref=e497]:
                  - paragraph [ref=e498]: IsoPSA
                  - paragraph [ref=e499]: Cleveland Diagnostics
                - generic [ref=e501]: TDS
              - generic [ref=e502]:
                - generic [ref=e503]: "Sens: 90.2%"
                - generic [ref=e504]: "Spec: 45.5%"
                - generic [ref=e505]: "TAT: 3d"
            - generic [ref=e506] [cursor=pointer]:
              - generic [ref=e507]:
                - generic [ref=e508]:
                  - paragraph [ref=e509]: Labcorp Plasma Detect
                  - paragraph [ref=e510]: Labcorp
                - generic [ref=e512]: MRD
              - generic [ref=e513]:
                - generic [ref=e514]: "Spec: 99.4%"
                - generic [ref=e515]: "TAT: 14d"
                - generic [ref=e516]: "Pubs: 2"
            - generic [ref=e517] [cursor=pointer]:
              - generic [ref=e518]:
                - generic [ref=e519]:
                  - paragraph [ref=e520]: Latitude
                  - paragraph [ref=e521]: Natera
                - generic [ref=e523]: MRD
              - generic [ref=e524]:
                - generic [ref=e525]: "Sens: 81%"
                - generic [ref=e526]: "Spec: 97%"
            - generic [ref=e527] [cursor=pointer]:
              - generic [ref=e528]:
                - generic [ref=e529]:
                  - paragraph [ref=e530]: LeukoStrat CDx FLT3 Mutation Assay
                  - paragraph [ref=e531]: Invivoscribe
                - generic [ref=e532]:
                  - generic "Laboratory IVD Kit" [ref=e533]: üî¨Kit
                  - generic [ref=e534]: TDS
              - generic [ref=e535]:
                - generic [ref=e536]: "TAT: 3d"
                - generic [ref=e537]: "Pubs: 50"
            - generic [ref=e538] [cursor=pointer]:
              - generic [ref=e539]:
                - generic [ref=e540]:
                  - paragraph [ref=e541]: LymphoTrack Dx IGH Assay
                  - paragraph [ref=e542]: Invivoscribe
                - generic [ref=e543]:
                  - generic "Laboratory IVD Kit" [ref=e544]: üî¨Kit
                  - generic [ref=e545]: MRD
              - generic [ref=e546]:
                - generic [ref=e547]: "Sens: 98%"
                - generic [ref=e548]: "Spec: 99%"
                - generic [ref=e549]: "TAT: 5d"
            - generic [ref=e550] [cursor=pointer]:
              - generic [ref=e551]:
                - generic [ref=e552]:
                  - paragraph [ref=e553]: LymphoVista
                  - paragraph [ref=e554]: LIQOMICS
                - generic [ref=e556]: MRD
              - generic [ref=e557]:
                - generic [ref=e558]: "Sens: 100%"
                - generic [ref=e559]: "Spec: 93%"
                - generic [ref=e560]: "TAT: 10d"
            - generic [ref=e561] [cursor=pointer]:
              - generic [ref=e562]:
                - generic [ref=e563]:
                  - paragraph [ref=e564]: MI Cancer Seek
                  - paragraph [ref=e565]: Caris Life Sciences
                - generic [ref=e567]: TDS
              - generic [ref=e569]: "TAT: 14d"
            - generic [ref=e570] [cursor=pointer]:
              - generic [ref=e571]:
                - generic [ref=e572]:
                  - paragraph [ref=e573]: MI Profile
                  - paragraph [ref=e574]: Caris Life Sciences
                - generic [ref=e576]: TDS
              - generic [ref=e578]: "TAT: 10d"
            - generic [ref=e579] [cursor=pointer]:
              - generic [ref=e580]:
                - generic [ref=e581]:
                  - paragraph [ref=e582]: MSK-IMPACT
                  - paragraph [ref=e583]: Memorial Sloan Kettering
                - generic [ref=e585]: TDS
              - generic [ref=e586]:
                - generic [ref=e587]: "TAT: 2d"
                - generic [ref=e588]: "Pubs: 1000"
            - generic [ref=e589] [cursor=pointer]:
              - generic [ref=e590]:
                - generic [ref=e591]:
                  - paragraph [ref=e592]: NavDx
                  - paragraph [ref=e593]: Naveris
                - generic [ref=e595]: MRD
              - generic [ref=e596]:
                - generic [ref=e597]: "Sens: 90.4%"
                - generic [ref=e598]: "Spec: 98.6%"
                - generic [ref=e599]: "Pubs: 35"
            - generic [ref=e600] [cursor=pointer]:
              - generic [ref=e601]:
                - generic [ref=e602]:
                  - paragraph [ref=e603]: NEO PanTracer Tissue
                  - paragraph [ref=e604]: NeoGenomics
                - generic [ref=e606]: TDS
              - generic [ref=e608]: "TAT: 7d"
            - generic [ref=e609] [cursor=pointer]:
              - generic [ref=e610]:
                - generic [ref=e611]:
                  - paragraph [ref=e612]: NeXT Personal
                  - paragraph [ref=e613]: Personalis
                - generic [ref=e615]: TRM
              - generic [ref=e617]: "Pubs: 5"
            - generic [ref=e618] [cursor=pointer]:
              - generic [ref=e619]:
                - generic [ref=e620]:
                  - paragraph [ref=e621]: NeXT Personal Dx
                  - paragraph [ref=e622]: Personalis
                - generic [ref=e624]: MRD
              - generic [ref=e625]:
                - generic [ref=e626]: "TAT: 21d"
                - generic [ref=e627]: "Pubs: 4"
            - generic [ref=e628] [cursor=pointer]:
              - generic [ref=e629]:
                - generic [ref=e630]:
                  - paragraph [ref=e631]: Northstar Response
                  - paragraph [ref=e632]: BillionToOne
                - generic [ref=e634]: TRM
              - generic [ref=e635]:
                - generic [ref=e636]: "TAT: 10d"
                - generic [ref=e637]: "Pubs: 5"
            - generic [ref=e638] [cursor=pointer]:
              - generic [ref=e639]:
                - generic [ref=e640]:
                  - paragraph [ref=e641]: Northstar Select
                  - paragraph [ref=e642]: BillionToOne
                - generic [ref=e644]: TDS
              - generic [ref=e645]:
                - generic [ref=e646]: "Spec: 99.9%"
                - generic [ref=e647]: "TAT: 5d"
                - generic [ref=e648]: "Pubs: 2"
            - generic [ref=e649] [cursor=pointer]:
              - generic [ref=e650]:
                - generic [ref=e651]:
                  - paragraph [ref=e652]: OmniSeq INSIGHT
                  - paragraph [ref=e653]: Labcorp Oncology (OmniSeq)
                - generic [ref=e655]: TDS
              - generic [ref=e657]: "TAT: 10d"
            - generic [ref=e658] [cursor=pointer]:
              - generic [ref=e659]:
                - generic [ref=e660]:
                  - paragraph [ref=e661]: OncoBEAM RAS CRC Kit
                  - paragraph [ref=e662]: Sysmex Inostics
                - generic [ref=e663]:
                  - generic "Laboratory IVD Kit" [ref=e664]: üî¨Kit
                  - generic [ref=e665]: TDS
              - generic [ref=e666]:
                - generic [ref=e667]: "Sens: 95%"
                - generic [ref=e668]: "Spec: 99%"
                - generic [ref=e669]: "TAT: 3d"
            - generic [ref=e670] [cursor=pointer]:
              - generic [ref=e671]:
                - generic [ref=e672]:
                  - paragraph [ref=e673]: Oncodetect
                  - paragraph [ref=e674]:
                    - text: Exact Sciences
                    - generic "Top 3 in OpenOnco Data Openness Ranking" [ref=e675]:
                      - generic [ref=e676]: üìä
                - generic [ref=e678]: MRD
              - generic [ref=e679]:
                - generic [ref=e680]: "Sens: 91%"
                - generic [ref=e681]: "Spec: 94%"
                - generic [ref=e682]: "TAT: 28d"
            - generic [ref=e683] [cursor=pointer]:
              - generic [ref=e684]:
                - generic [ref=e685]:
                  - paragraph [ref=e686]: OncoExTra
                  - paragraph [ref=e687]:
                    - text: Exact Sciences
                    - generic "Top 3 in OpenOnco Data Openness Ranking" [ref=e688]:
                      - generic [ref=e689]: üìä
                - generic [ref=e691]: TDS
              - generic [ref=e693]: "TAT: 10d"
            - generic [ref=e694] [cursor=pointer]:
              - generic [ref=e695]:
                - generic [ref=e696]:
                  - paragraph [ref=e697]: Oncoguard Liver
                  - paragraph [ref=e698]:
                    - text: Exact Sciences
                    - generic "Top 3 in OpenOnco Data Openness Ranking" [ref=e699]:
                      - generic [ref=e700]: üìä
                - generic [ref=e702]: ECD
              - generic [ref=e703]:
                - generic [ref=e704]: "Sens: 88%"
                - generic [ref=e705]: "Spec: 87%"
                - generic [ref=e706]: "Pubs: 3"
            - generic [ref=e707] [cursor=pointer]:
              - generic [ref=e708]:
                - generic [ref=e709]:
                  - paragraph [ref=e710]: Oncomine Comprehensive Assay Plus
                  - paragraph [ref=e711]: Thermo Fisher Scientific
                - generic [ref=e712]:
                  - generic "Laboratory IVD Kit" [ref=e713]: üî¨Kit
                  - generic [ref=e714]: TDS
              - generic [ref=e715]:
                - generic [ref=e716]: "TAT: 5d"
                - generic [ref=e717]: "Pubs: 80"
            - generic [ref=e718] [cursor=pointer]:
              - generic [ref=e719]:
                - generic [ref=e720]:
                  - paragraph [ref=e721]: Pathlight
                  - paragraph [ref=e722]: SAGA Diagnostics
                - generic [ref=e724]: MRD
              - generic [ref=e725]:
                - generic [ref=e726]: "TAT: 28d"
                - generic [ref=e727]: "Pubs: 8"
            - generic [ref=e728] [cursor=pointer]:
              - generic [ref=e729]:
                - generic [ref=e730]:
                  - paragraph [ref=e731]: PGDx elio plasma focus Dx
                  - paragraph [ref=e732]: Labcorp (Personal Genome Diagnostics)
                - generic [ref=e733]:
                  - generic "Laboratory IVD Kit" [ref=e734]: üî¨Kit
                  - generic [ref=e735]: TDS
              - generic [ref=e736]:
                - generic [ref=e737]: "Sens: 90%"
                - generic [ref=e738]: "Spec: 95%"
                - generic [ref=e739]: "TAT: 5d"
            - generic [ref=e740] [cursor=pointer]:
              - generic [ref=e741]:
                - generic [ref=e742]:
                  - paragraph [ref=e743]: PGDx elio tissue complete
                  - paragraph [ref=e744]: Labcorp (Personal Genome Diagnostics)
                - generic [ref=e745]:
                  - generic "Laboratory IVD Kit" [ref=e746]: üî¨Kit
                  - generic [ref=e747]: TDS
              - generic [ref=e748]:
                - generic [ref=e749]: "TAT: 10d"
                - generic [ref=e750]: "Pubs: 30"
            - generic [ref=e751] [cursor=pointer]:
              - generic [ref=e752]:
                - generic [ref=e753]:
                  - paragraph [ref=e754]: ProVue Lung
                  - paragraph [ref=e755]: PrognomiQ
                - generic [ref=e757]: ECD
              - generic [ref=e758]:
                - generic [ref=e759]: "Sens: 85%"
                - generic [ref=e760]: "Spec: 55%"
            - generic [ref=e761] [cursor=pointer]:
              - generic [ref=e762]:
                - generic [ref=e763]:
                  - paragraph [ref=e764]: RaDaR
                  - paragraph [ref=e765]: NeoGenomics
                - generic [ref=e767]: TRM
              - generic [ref=e769]: "Pubs: 15"
            - generic [ref=e770] [cursor=pointer]:
              - generic [ref=e771]:
                - generic [ref=e772]:
                  - paragraph [ref=e773]: RaDaR ST
                  - paragraph [ref=e774]: NeoGenomics
                - generic [ref=e776]: MRD
              - generic [ref=e777]:
                - generic [ref=e778]: "Sens: 95.7%"
                - generic [ref=e779]: "Spec: 91%"
                - generic [ref=e780]: "TAT: 35d"
            - generic [ref=e781] [cursor=pointer]:
              - generic [ref=e782]:
                - generic [ref=e783]:
                  - paragraph [ref=e784]: Reveal MRD
                  - paragraph [ref=e785]: Guardant Health
                - generic [ref=e787]: MRD
              - generic [ref=e788]:
                - generic [ref=e789]: "Sens: 81%"
                - generic [ref=e790]: "Spec: 98%"
                - generic [ref=e791]: "TAT: 7d"
            - generic [ref=e792] [cursor=pointer]:
              - generic [ref=e793]:
                - generic [ref=e794]:
                  - paragraph [ref=e795]: Reveal TRM
                  - paragraph [ref=e796]: Guardant Health
                - generic [ref=e798]: TRM
              - generic [ref=e799]:
                - generic [ref=e800]: "TAT: 7d"
                - generic [ref=e801]: "Pubs: 80"
            - generic [ref=e802] [cursor=pointer]:
              - generic [ref=e803]:
                - generic [ref=e804]:
                  - paragraph [ref=e805]: Shield
                  - paragraph [ref=e806]: Guardant Health
                - generic [ref=e808]: ECD
              - generic [ref=e809]:
                - generic [ref=e810]: "Sens: 83.1%"
                - generic [ref=e811]: "Spec: 89.6%"
                - generic [ref=e812]: "Pubs: 5"
            - generic [ref=e813] [cursor=pointer]:
              - generic [ref=e814]:
                - generic [ref=e815]:
                  - paragraph [ref=e816]: Shield MCD
                  - paragraph [ref=e817]: Guardant Health
                - generic [ref=e819]: ECD
              - generic [ref=e820]:
                - generic [ref=e821]: "Sens: 60%"
                - generic [ref=e822]: "Spec: 98.5%"
            - generic [ref=e823] [cursor=pointer]:
              - generic [ref=e824]:
                - generic [ref=e825]:
                  - paragraph [ref=e826]: Signal-C
                  - paragraph [ref=e827]: Universal DX
                - generic [ref=e829]: ECD
              - generic [ref=e830]:
                - generic [ref=e831]: "Sens: 93%"
                - generic [ref=e832]: "Spec: 92%"
                - generic [ref=e833]: "Pubs: 3"
            - generic [ref=e834] [cursor=pointer]:
              - generic [ref=e835]:
                - generic [ref=e836]:
                  - paragraph [ref=e837]: Signatera
                  - paragraph [ref=e838]: Natera
                - generic [ref=e840]: MRD
              - generic [ref=e841]:
                - generic [ref=e842]: "Sens: 94%"
                - generic [ref=e843]: "Spec: 98%"
                - generic [ref=e844]: "TAT: 28d"
            - generic [ref=e845] [cursor=pointer]:
              - generic [ref=e846]:
                - generic [ref=e847]:
                  - paragraph [ref=e848]: Signatera (IO Monitoring)
                  - paragraph [ref=e849]: Natera
                - generic [ref=e851]: TRM
              - generic [ref=e853]: "Pubs: 125"
            - generic [ref=e854] [cursor=pointer]:
              - generic [ref=e855]:
                - generic [ref=e856]:
                  - paragraph [ref=e857]: Signatera Genome
                  - paragraph [ref=e858]: Natera
                - generic [ref=e860]: MRD
              - generic [ref=e861]:
                - generic [ref=e862]: "Sens: 94%"
                - generic [ref=e863]: "Spec: 100%"
                - generic [ref=e864]: "TAT: 28d"
            - generic [ref=e865] [cursor=pointer]:
              - generic [ref=e866]:
                - generic [ref=e867]:
                  - paragraph [ref=e868]: StrataNGS
                  - paragraph [ref=e869]: Strata Oncology
                - generic [ref=e871]: TDS
              - generic [ref=e873]: "TAT: 7d"
            - generic [ref=e874] [cursor=pointer]:
              - generic [ref=e875]:
                - generic [ref=e876]:
                  - paragraph [ref=e877]: Tempus xF
                  - paragraph [ref=e878]: Tempus AI
                - generic [ref=e880]: TDS
              - generic [ref=e881]:
                - generic [ref=e882]: "Sens: >99%"
                - generic [ref=e883]: "Spec: >99.9%"
                - generic [ref=e884]: "TAT: 5d"
            - generic [ref=e885] [cursor=pointer]:
              - generic [ref=e886]:
                - generic [ref=e887]:
                  - paragraph [ref=e888]: Tempus xF+
                  - paragraph [ref=e889]: Tempus AI
                - generic [ref=e891]: TDS
              - generic [ref=e893]: "TAT: 7d"
            - generic [ref=e894] [cursor=pointer]:
              - generic [ref=e895]:
                - generic [ref=e896]:
                  - paragraph [ref=e897]: Tempus xM for TRM
                  - paragraph [ref=e898]: Tempus
                - generic [ref=e900]: TRM
              - generic [ref=e902]: "Pubs: 3"
            - generic [ref=e903] [cursor=pointer]:
              - generic [ref=e904]:
                - generic [ref=e905]:
                  - paragraph [ref=e906]: Tempus xM MRD
                  - paragraph [ref=e907]: Tempus
                - generic [ref=e909]: MRD
              - generic [ref=e911]: "Pubs: 3"
            - generic [ref=e912] [cursor=pointer]:
              - generic [ref=e913]:
                - generic [ref=e914]:
                  - paragraph [ref=e915]: Tempus xT CDx
                  - paragraph [ref=e916]: Tempus AI
                - generic [ref=e918]: TDS
              - generic [ref=e919]:
                - generic [ref=e920]: "TAT: 14d"
                - generic [ref=e921]: "$: 4.5k"
            - generic [ref=e922] [cursor=pointer]:
              - generic [ref=e923]:
                - generic [ref=e924]:
                  - paragraph [ref=e925]: therascreen EGFR RGQ PCR Kit
                  - paragraph [ref=e926]: QIAGEN
                - generic [ref=e927]:
                  - generic "Laboratory IVD Kit" [ref=e928]: üî¨Kit
                  - generic [ref=e929]: TDS
              - generic [ref=e930]:
                - generic [ref=e931]: "Sens: 80%"
                - generic [ref=e932]: "Spec: 98%"
                - generic [ref=e933]: "TAT: 1d"
            - generic [ref=e934] [cursor=pointer]:
              - generic [ref=e935]:
                - generic [ref=e936]:
                  - paragraph [ref=e937]: TruSight Oncology Comprehensive (TSO Comp)
                  - paragraph [ref=e938]: Illumina
                - generic [ref=e939]:
                  - generic "Laboratory IVD Kit" [ref=e940]: üî¨Kit
                  - generic [ref=e941]: TDS
              - generic [ref=e942]:
                - generic [ref=e943]: "TAT: 10d"
                - generic [ref=e944]: "Pubs: 50"
            - generic [ref=e945] [cursor=pointer]:
              - generic [ref=e946]:
                - generic [ref=e947]:
                  - paragraph [ref=e948]: TSO 500
                  - paragraph [ref=e949]: Illumina
                - generic [ref=e950]:
                  - generic "Laboratory IVD Kit" [ref=e951]: üî¨Kit
                  - generic [ref=e952]: TDS
              - generic [ref=e953]:
                - generic [ref=e954]: "TAT: 7d"
                - generic [ref=e955]: "Pubs: 200"
            - generic [ref=e956] [cursor=pointer]:
              - generic [ref=e957]:
                - generic [ref=e958]:
                  - paragraph [ref=e959]: Veracyte MRD (C2i Genomics platform)
                  - paragraph [ref=e960]: Veracyte (C2i Genomics)
                - generic [ref=e962]: MRD
              - generic [ref=e963]:
                - generic [ref=e964]: "Sens: 91%"
                - generic [ref=e965]: "Spec: 88%"
                - generic [ref=e966]: "TAT: 14d"
          - generic [ref=e967]:
            - generic [ref=e968]:
              - generic [ref=e969]: üî¨Kit
              - generic [ref=e970]: IVD Kit
            - generic [ref=e971]:
              - generic [ref=e972]: üè†Home
              - generic [ref=e973]: Self-Collect
            - generic [ref=e974]: "|"
            - generic [ref=e977]: ECD
            - generic [ref=e980]: TDS
            - generic [ref=e983]: TRM
            - generic [ref=e986]: MRD
      - generic [ref=e988]:
        - generic [ref=e989]:
          - heading "Data Openness Overview" [level=2] [ref=e990]
          - generic [ref=e991]: Updated Dec 14,
        - generic [ref=e992]:
          - generic [ref=e993]:
            - heading "Top 3 Vendors by Data Openness" [level=3] [ref=e994]
            - generic [ref=e995]: Min. 2 tests to qualify
          - generic [ref=e996]:
            - generic [ref=e997]:
              - generic [ref=e999]: "1"
              - generic [ref=e1000]:
                - paragraph [ref=e1001]: Adaptive Biotechnologies
                - paragraph [ref=e1002]: 2 tests
                - generic [ref=e1003]:
                  - generic [ref=e1004]: "85"
                  - generic [ref=e1005]: vs
                  - generic [ref=e1006]: "53"
                  - generic [ref=e1007]: (Avg)
            - generic [ref=e1008]:
              - generic [ref=e1010]: "2"
              - generic [ref=e1011]:
                - paragraph [ref=e1012]: Exact Sciences
                - paragraph [ref=e1013]: 6 tests
                - generic [ref=e1014]:
                  - generic [ref=e1015]: "79"
                  - generic [ref=e1016]: vs
                  - generic [ref=e1017]: "53"
                  - generic [ref=e1018]: (Avg)
            - generic [ref=e1019]:
              - generic [ref=e1021]: "3"
              - generic [ref=e1022]:
                - paragraph [ref=e1023]: Illumina
                - paragraph [ref=e1024]: 2 tests
                - generic [ref=e1025]:
                  - generic [ref=e1026]: "70"
                  - generic [ref=e1027]: vs
                  - generic [ref=e1028]: "53"
                  - generic [ref=e1029]: (Avg)
          - generic [ref=e1030]:
            - generic [ref=e1031]:
              - generic [ref=e1032]: 15 vendors with 2+ tests
              - generic [ref=e1033]: ‚Ä¢
              - generic [ref=e1034]: 45 changelog entries
            - button "Methodology" [ref=e1035] [cursor=pointer]:
              - text: Methodology
              - img [ref=e1036]
        - generic [ref=e1038]:
          - heading "Data Completeness by Field" [level=3] [ref=e1039]
          - generic [ref=e1040]:
            - generic [ref=e1042]:
              - generic [ref=e1043]:
                - generic [ref=e1044]: List Price
                - generic [ref=e1045]: published pricing
              - generic [ref=e1046]: 22%
            - generic [ref=e1050]:
              - generic [ref=e1051]:
                - generic [ref=e1052]: Sensitivity
                - generic [ref=e1053]: detection rate
              - generic [ref=e1054]: 51%
            - generic [ref=e1058]:
              - generic [ref=e1059]:
                - generic [ref=e1060]: Specificity
                - generic [ref=e1061]: true negative rate
              - generic [ref=e1062]: 56%
            - generic [ref=e1066]:
              - generic [ref=e1067]:
                - generic [ref=e1068]: TAT
                - generic [ref=e1069]: turnaround time
              - generic [ref=e1070]: 84%
            - generic [ref=e1074]:
              - generic [ref=e1075]:
                - generic [ref=e1076]: Publications
                - generic [ref=e1077]: peer-reviewed
              - generic [ref=e1078]: 80%
          - paragraph [ref=e1081]: Completeness rates reflect publicly available data across 79 tests from 43 vendors.
  - contentinfo [ref=e1082]:
    - generic [ref=e1083]:
      - paragraph [ref=e1084]:
        - strong [ref=e1085]: "Disclaimer:"
        - text: OpenOnco is provided for informational and educational purposes only. The information on this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options. OpenOnco does not recommend or endorse any specific tests, physicians, products, procedures, or opinions. Nothing on this website constitutes reimbursement or coverage guidance, and should not be used to determine insurance coverage, patient financial responsibility, or billing practices. Reliance on any information provided by OpenOnco is solely at your own risk. Test performance data, pricing, and availability are subject to change and should be verified directly with test vendors.
      - paragraph [ref=e1086]: "Built: Dec 14, 2025, 10:05 PM PST"
```